Qatar vs Slovenia: Cause of death, by non-communicable diseases, ages 60+, male
Qatar
76.6%
in 2021
Slovenia
77.2%
in 2021
Qatar rank
63rd
Slovenia rank
61st
Cause of death, by non-communicable diseases, ages 60+, male over time
- Qatar
- Slovenia
How they compare
Slovenia currently reports 77.2% against 76.6% in Qatar, a difference of 0.6%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Qatar ahead.
Qatar ranks 63rd and Slovenia ranks 61st of 185 countries.
Qatar has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Qatar | Slovenia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 92.4% | 89.8% | 2.6% | Qatar |
| 2010s | 91.5% | 90.6% | 0.9% | Qatar |
| 2020s | 78.4% | 77.0% | 1.4% | Qatar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, male, Qatar or Slovenia?
- Slovenia, at 77.2% against 76.6% in Qatar as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+, male between Qatar and Slovenia?
- 0.6%, with Slovenia ahead.
- How many years of comparable data are there for Qatar and Slovenia?
- 6 years are reported by both, from 2000 to 2021.
- How do Qatar and Slovenia rank globally for cause of death, by non-communicable diseases, ages 60+, male?
- Qatar ranks 63rd and Slovenia ranks 61st of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+, male (% of total male deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 60+ due to non-communicable diseases divided by number of all male deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.